To include your compound in the COVID-19 Resource Center, submit it here.

A low-density lipoprotein receptor identified as tauopathy target

DISEASE CATEGORY: Neurology

INDICATION: Neurology

Inhibiting the low-density lipoprotein receptor LRP1 could treat tauopathies such as Alzheimer’s disease,

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE